Interview: The commercialization of regenerative medicine into a routine healthcare offering

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.8, Iss.3, 2013-05, pp. : 251-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interview: Immunogenicity: the elephant in the room for regenerative medicine?

By Fairchild Paul

Regenerative Medicine, Vol. 8, Iss. 1, 2013-01 ,pp. : 23-26

Future Medicine

Access to resources Recommend Favorite

Interview: Commercial translation of cell-based therapies and regenerative medicine: learning by experience

By Haseltine William A

Regenerative Medicine, Vol. 6, Iss. 4, 2011-07 ,pp. : 431-435

Future Medicine

Access to resources Recommend Favorite

Regenerative medicine

By Minger Stephen L

Regenerative Medicine, Vol. 1, Iss. 1, 2006-01 ,pp. : 1-2

Future Medicine

Access to resources Recommend Favorite

The UK relative to other single payer-dominated healthcare markets for regenerative medicine therapies

By Rose James B Williams David J

Regenerative Medicine, Vol. 7, Iss. 3, 2012-05 ,pp. : 429-438

Future Medicine

Access to resources Recommend Favorite

Nanotechnology for regenerative medicine

By Khang Dongwoo

Biomedical Microdevices, Vol. 12, Iss. 4, 2010-08 ,pp. : 575-587

Springer Publishing Company

Access to resources Recommend Favorite